Corazon (Corsee) D. Sanders, Director at Ultragenyx Pharmaceutical Inc. (RARE), sold 2,970 shares at $51.65 ($153K) on 2023-06-08, disclosed to the SEC on 2023-06-09.
Open-market sale of $153k RARE by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.65 | 1,485 | $77K | 50.0% |
| 2 | $51.65 | 1,485 | $77K | 50.0% |
| Total | $51.65 avg | 2,970 | $153K | 100% |
| Filing → |
| ONC | SELL | 2025-12-01 | $1.8M | — | Filing → |
| ONC | SELL | 2025-09-09 | $898K | — | Filing → |
| RARE | SELL | 2025-06-23 | $180K | — | Filing → |